Sotkamo Silver AB Logo

Sotkamo Silver AB

Mines silver, gold, and zinc in Finland to supply essential metals for green technologies.

SOSI | HE

Overview

Corporate Details

ISIN(s):
SE0001057910 (+3 more)
LEI:
213800R2TQW1OZGYDX93
Country:
Sweden
Address:
NYBROGATAN 34/BOX 5216, 102 45 STOCKHOLM
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Sotkamo Silver AB is a mining and ore prospecting company that develops and utilizes mineral deposits. The company's core operations are focused on the exploration and production of silver, gold, and zinc, primarily from its Silver Mine project located in the Kainuu region of Finland. Sotkamo Silver's business model is centered on developing mineral resources in a responsible manner that considers environmental and societal factors. The company aims to support the global shift toward green technologies by supplying essential metals, positioning its products as both an opportunity and a necessity for a sustainable future.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-29 09:00
Declaration of Voting Results & Voting Rights Announcements
Sotkamo Silver AB: Nytt antal aktier och röster
Swedish 191.2 KB
2025-08-29 09:00
Declaration of Voting Results & Voting Rights Announcements
Sotkamo Silver AB: Uusi osakkeiden ja äänten määrä
Finnish 183.7 KB
2025-08-29 09:00
Declaration of Voting Results & Voting Rights Announcements
Sotkamo Silver AB: New number of shares and votes
English 185.5 KB
2025-08-22 15:40
Capital/Financing Update
Sotkamo Silver AB har ingått ett avtal om förlängning av löptiden för sitt seni…
Swedish 178.0 KB
2025-08-22 15:40
Capital/Financing Update
Sotkamo Silver on sopinut seniorlainan maturiteetin pidentämisestä ja yhden mil…
Finnish 184.3 KB
2025-08-22 15:40
Capital/Financing Update
Sotkamo Silver has agreed on the extension of the senior loan maturity and an a…
English 178.1 KB
2025-08-13 18:25
Share Issue/Capital Change
Sotkamo Silver offentliggör slutligt utfall i utbyteserbjudandet och att styrel…
Swedish 199.5 KB
2025-08-13 18:25
Share Issue/Capital Change
Sotkamo Silver announces final results in the exchange offer and that the Board…
English 200.4 KB
2025-08-13 18:25
Share Issue/Capital Change
Sotkamo Silver julkistaa vaihtotarjouksen lopulliset tulokset sekä hallituksen …
Finnish 195.5 KB
2025-08-01 10:30
Related Party Transaction
SISÄPIIRITIETO: Sotkamo Silver tekee vaihtotarjouksen yhtiön 6,3 miljoonan euro…
Finnish 203.8 KB
2025-08-01 10:30
Share Issue/Capital Change
INSIDERINFORMATION: Sotkamo Silver offentliggör utbyteserbjudande till innehava…
Swedish 207.6 KB
2025-08-01 10:30
Share Issue/Capital Change
INSIDER INFORMATION: Sotkamo Silver launches exchange offer to the holders of t…
English 207.7 KB
2025-07-31 08:00
Interim Report
Swedish 2.4 MB
2025-07-31 08:00
Interim Report
English 2.3 MB
2025-07-23 16:55
Capital/Financing Update
SOTKAMO SILVER AB, SISÄPIIRITIETO: Seniorlainan haltijat antoivat ehdollisen si…
Finnish 185.1 KB

Automate Your Workflow. Get a real-time feed of all Sotkamo Silver AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Sotkamo Silver AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Poxel Logo
Develops drugs for metabolic diseases, including NASH, rare diseases, and an approved diabetes drug.
France POXEL
PRAP Japan,Inc. Logo
A PR & communications firm building brand reputation for corporate clients in diverse industries.
Japan 2449
Psomagen, Inc. Logo
A CRO providing multiomics services & data analysis for academic, biotech, and pharma researchers.
United States of America 950200
Public Policy Holding Company, Inc. Logo
Advisory group providing public policy, government relations, and strategic communications services.
United States of America PPHC.L
Purple Biotech Ltd. Logo
Developing cancer therapies to overcome tumor immune evasion and drug resistance.
Israel PPBT
QUIA PHARMA AB Logo
Develops biobetters by enhancing approved drugs with a patented drug delivery platform.
Sweden QUIA
Qurient Co., Ltd. Logo
Biopharma developing novel drugs for cancer, inflammation, and infectious diseases.
South Korea 115180
RaQualia Pharma Inc. Logo
An R&D firm discovering novel small molecules for out-licensing to pharma partners.
Japan 4579
Recruit Holdings Co., Ltd. Logo
Global provider of HR tech (Indeed), staffing services, and business SaaS solutions.
Japan 6098
Renascience Inc. Logo
Develops innovative drugs and AI-powered medical devices for aging and hereditary diseases.
Japan 4889

Talk to a Data Expert

Have a question? We'll get back to you promptly.